Abstract:Rationale: Hypertension represents a major risk factor for stroke, myocardial infarction, and heart failure and affects 30% of the adult population. Mitochondrial dysfunction contributes to hypertension, but specific mechanisms are unclear. The mitochondrial deacetylase Sirt3 is critical in the regulation of metabolic and antioxidant functions which are associated with hypertension, and cardiovascular disease risk factors diminish Sirt3 level. Objective: We hypothesized that reduced Sirt3 expression contributes to vascular dysfunction in hypertension but increased Sirt3 protects vascular function and decreases hypertension. Methods and Results: To test the therapeutic potential of targeting Sirt3 expression we developed new transgenic mice with global Sirt3 overexpression (Sirt3OX) which protects from endothelial dysfunction, vascular oxidative stress and hypertrophy, attenuates angiotensin II- and DOCA-salt induced hypertension. Global Sirt3 depletion in Sirt3 -/- mice results in oxidative stress due to SOD2 hyperacetylation, increases HIF1α, reduces endothelial cadherin, stimulates vascular hypertrophy, increases vascular permeability and vascular inflammation (p65, caspase 1, VCAM, ICAM and MCP1), increases inflammatory cell infiltration in the kidney, reduces telomerase expression, and accelerates vascular senescence and age-dependent hypertension; conversely, increased Sirt3 expression in Sirt3OX mice prevents these deleterious effects. The clinical relevance of Sirt3 depletion was confirmed in arterioles from human mediastinal fat in patients with essential hypertension showing a 40% decrease in vascular Sirt3, coupled with Sirt3 dependent 3-fold increases in SOD2 acetylation, NfKB activity, VCAM, ICAM and MCP1 levels in hypertensive subjects compared with normotensive subjects. Conclusions: We suggest that Sirt3 depletion in hypertension promotes endothelial dysfunction, vascular hypertrophy, vascular inflammation and end-organ damage. Our data support a therapeutic potential of targeting Sirt3 expression in vascular dysfunction and hypertension.

Sirt3 Overexpression Alleviates Hyperglycemia-Induced Vascular Inflammation Through Regulating Redox Balance, Cell Survival, and AMPK-mediated Mitochondrial Homeostasis

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

SIRT3 attenuates coronary atherosclerosis in diabetic patients by regulating endothelial cell function

SIRT3 Mitigates High Glucose-Induced Damage in Retinal Microvascular Endothelial Cells Via OPA1-mediated Mitochondrial Dynamics

Sirt3 Protects Retinal Pigment Epithelial Cells From High Glucose-Induced Injury by Promoting Mitophagy Through the AMPK/mTOR/ULK1 Pathway

High-glucose treatment regulates biological functions of human umbilical vein endothelial cells via Sirt1/FOXO3 pathway

SIRT3 protects endothelial cells from high glucose-induced senescence and dysfunction via the p53 pathway

Sirtuin (sirt) 3 Overexpression Prevents Retinopathy in Streptozotocin-Induced Diabetic Rats.

Potential Suppression of the High Glucose and Insulin-Induced Retinal Neovascularization by Sirtuin 3 in the Human Retinal Endothelial Cells.

Sirt3 Deficiency Exacerbates Diabetic Cardiac Dysfunction: Role of Foxo3A-Parkin-mediated Mitophagy.

Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence

Sirt3 Deficiency Increased the Vulnerability of Pancreatic Beta Cells to Oxidative Stress-Induced Dysfunction

SIRT3 Modulates Endothelial Mitochondrial Redox State during Insulin Resistance

Sirtuin-3 (SIRT3) protects pancreatic β-cells from endoplasmic reticulum (ER) stress-induced apoptosis and dysfunction

SIRT3 is a Downstream Target of PPAR-α Implicated in High Glucose-Induced Cardiomyocyte Injury in AC16 Cells.

SIRT-3 Modulation by Resveratrol Improves Mitochondrial Oxidative Phosphorylation in Diabetic Heart through Deacetylation of TFAM

Sirtuin 3 Governs Autophagy‐dependent Glycolysis During Angiotensin II‐induced Endothelial‐to‐mesenchymal Transition

Decreased Sirt3 Contributes to Cyclic Production of Reactive Oxygen Species and Islet Β-Cell Apoptosis in High Glucose Conditions

SIRT3 alleviates high glucose-induced chondrocyte injury through the promotion of autophagy and suppression of apoptosis in osteoarthritis progression

Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress

AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs’ Dysfunction and Strengthened Anti-oxidant Capacity